Vaccinated group (n = 131) | VH group (n = 39) | p-value | |
---|---|---|---|
Gender (male/female) | 69/62 | 13/26 | 0.044 |
History of Hypertension (n,%) | 69, 52.7% | 25, 64.1% | 0.271 |
History of drug allergy (n,%) | 32, 24.4% | 8, 20.5% | 0.673 |
Autoimmune diseases (n,%) | 0, 0% | 0, 0% | - |
Duration of diabetes (year) | 8.2 ± 7.4 | 8.9 ± 7.7 | 0.585 |
Baseline types of glucose lowering drugs (n) | 2.1 ± 1.2 | 2.3 ± 1.2 | 0.281 |
Baseline HbA1c (%) | 6.56 ± 0.95 | 7.54 ± 2.01 | < 0.001 |
Baseline FBG (mmol/L) | 6.51 ± 1.04 | 7.13 ± 2.40 | 0.053 |
Baseline PBG (mmol/L) | 8.32 ± 1.97 | 9.44 ± 2.94 | 0.015 |